The main purpose of this legislation is to prevent the use of federal funds for the implementation, administration, or enforcement of a specific rule by the Food and Drug Administration (FDA) concerning laboratory developed tests (LDTs) and medical devices. The bill aims to halt any financial support for this rule, which was published in May 2024. Key provisions of this legislation include a clear prohibition on the use of federal money for the FDA's final rule regarding medical devices and laboratory developed tests.